Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JEFFERY A ALLEN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1982894010
CMS profile
903699
Location
MINNEAPOLIS, MN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$229,948.93

215 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Alexion Pharmaceuticals, Inc. $50,532.54 48
ARGENX US, INC. $47,342.35 35
CSL Behring $39,392.44 31
Alnylam Pharmaceuticals Inc. $37,044.01 49
Takeda Pharmaceuticals U.S.A., Inc. $28,386.11 31
EMD Serono Research & Development Institute, Inc. $10,610.95 2
GENZYME CORPORATION $9,563.29 6
Octapharma USA, Inc. $7,077.24 13

Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JEFFERY A ALLEN

NPI 1982894010 · CMS profile ID 903699

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

MINNEAPOLIS, MN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1982894010?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JEFFERY A ALLEN, NPI 1982894010, CMS profile ID 903699. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1982894010?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JEFFERY A ALLEN, NPI 1982894010, CMS profile ID 903699. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1982894010?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JEFFERY A ALLEN, NPI 1982894010, CMS profile ID 903699, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 215 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1982894010?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

215 matching records · $229,948.93 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 215 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 215.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $59.9210/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050354587 CMS
GENZYME CORPORATION $8,638.0010/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050354591 CMS
Alnylam Pharmaceuticals Inc. $1,030.0010/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006132465 CMS
Alnylam Pharmaceuticals Inc. $71.0610/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006132791 CMS
Takeda Pharmaceuticals U.S.A., Inc. $5.3510/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331505 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9.0010/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331509 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.2210/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331513 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7,115.6310/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331517 CMS
Takeda Pharmaceuticals U.S.A., Inc. $42.0010/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331521 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.6510/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331523 CMS
Alnylam Pharmaceuticals Inc. $2,575.0010/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006132491 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,546.8809/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331501 CMS
Takeda Pharmaceuticals U.S.A., Inc. $120.3009/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331487 CMS
Takeda Pharmaceuticals U.S.A., Inc. $373.0009/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331489 CMS
Takeda Pharmaceuticals U.S.A., Inc. $685.2209/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331493 CMS
Takeda Pharmaceuticals U.S.A., Inc. $658.1409/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055331497 CMS
Alexion Pharmaceuticals, Inc. $200.0909/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016995117 CMS
Alexion Pharmaceuticals, Inc. $30.0009/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017080315 CMS
Alexion Pharmaceuticals, Inc. $23.8509/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017086579 CMS
Octapharma USA, Inc. $6,000.0009/16/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716083 CMS
Octapharma USA, Inc. $60.1109/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716089 CMS
Octapharma USA, Inc. $60.0009/16/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716093 CMS
Octapharma USA, Inc. $36.7009/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716101 CMS
Octapharma USA, Inc. $69.3909/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716107 CMS
Octapharma USA, Inc. $36.7009/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716115 CMS
Octapharma USA, Inc. $10.7909/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716121 CMS
Octapharma USA, Inc. $6.0309/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716129 CMS
Octapharma USA, Inc. $17.0009/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716137 CMS
Octapharma USA, Inc. $20.3809/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716143 CMS
Octapharma USA, Inc. $479.1409/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716149 CMS
Octapharma USA, Inc. $134.0009/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716157 CMS
Octapharma USA, Inc. $147.0009/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716163 CMS
Alexion Pharmaceuticals, Inc. $4,720.0009/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016977157 CMS
CSL Behring $5,610.0009/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043035777 CMS
Alexion Pharmaceuticals, Inc. $697.8109/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016985211 CMS
Alexion Pharmaceuticals, Inc. $70.8809/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016994523 CMS
Alexion Pharmaceuticals, Inc. $202.5609/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017006955 CMS
Alexion Pharmaceuticals, Inc. $23.7109/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016995243 CMS
Alexion Pharmaceuticals, Inc. $4,720.0009/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017016931 CMS
Alexion Pharmaceuticals, Inc. $30.0009/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017072469 CMS
Alexion Pharmaceuticals, Inc. $140.1708/31/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017007519 CMS
CSL Behring $124.9908/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043035761 CMS
CSL Behring $980.7608/31/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043035768 CMS
Alexion Pharmaceuticals, Inc. $627.8008/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017007089 CMS
Alexion Pharmaceuticals, Inc. $122.9008/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017019129 CMS
Alexion Pharmaceuticals, Inc. $81.4108/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017090133 CMS
CSL Behring $8.3308/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043035729 CMS
CSL Behring $9.0008/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043035737 CMS
CSL Behring $5,610.0008/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043035745 CMS
CSL Behring $54.0008/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043035753 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $107,998.01 121
PY2020 $26,942.62 15
PY2021 $45,182.52 34
PY2022 $127,615.69 72
PY2023 $229,948.93 215
PY2024 $317,982.39 241
PY2025 $270,173.46 134

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $40,431.00 4
PY2024 Recipient $3,450.00 2
PY2024 Principal investigator $3,114.52 2
PY2023 Principal investigator $49,172.79 13
PY2022 Principal investigator $45,415.00 6
PY2021 Recipient $3,587.50 2
PY2021 Principal investigator $224,020.88 6
PY2020 Principal investigator $34,861.00 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI US SERVICES INC. $31,431.00 09/03/2025 Non-covered Recipient Entity
Regents Of The University Of Minnesota
A Phase 3, Doubleblind, Placebocontrolled Study Evaluating Efficacy and Safety of Riliprubart in Participants With Refractory Chronic Inflammatory Demyelinating Polyneuropathy No dispute reported 06/30/2026 1226157452
Principal investigator 1 SANOFI US SERVICES INC. $4,500.00 02/24/2025 Non-covered Recipient Entity
Regents Of The University Of Minnesota
A Phase 2, Multicenter, Open-label, Proof-of-concept Study Evaluating the Efficacy, Safety, and Tolerability of BIVV020 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) No dispute reported 06/30/2026 1226157210
Principal investigator 1 SANOFI US SERVICES INC. $1,500.00 02/24/2025 Non-covered Recipient Entity
Regents Of The University Of Minnesota
A Phase 2, Multicenter, Open-label, Proof-of-concept Study Evaluating the Efficacy, Safety, and Tolerability of BIVV020 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) No dispute reported 06/30/2026 1226157260
Principal investigator 1 SANOFI US SERVICES INC. $3,000.00 02/24/2025 Non-covered Recipient Entity
Regents Of The University Of Minnesota
A Phase 2, Multicenter, Open-label, Proof-of-concept Study Evaluating the Efficacy, Safety, and Tolerability of BIVV020 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) No dispute reported 06/30/2026 1226157263